Last reviewed · How we verify
Castleman's disease
Approved treatments
- Roactemra · Roche
Roactemra works by blocking the interleukin-6 receptor, a protein that plays a key role in inflammation.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Castleman's disease patent landscape — cliff calendar, originator estates, attackable patents
- Castleman's disease treatment landscape brief
- Castleman's disease treatment updates RSS
Frequently asked questions about Castleman's disease
What drugs treat Castleman's disease?
Tracked treatments include Roactemra.
What is the treatment for Castleman's disease?
Standard treatment for Castleman's disease includes Roactemra. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Castleman's disease patent cliff · Castleman's disease CI report
- Treatment: Roactemra · Roche
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing